Stock Chart
HIND
$1.99
-1.97%
Score:
64.3
HOLD
Pro
Screener
Vol:
0.38x
(vs SPY: 1.2x | vs QQQ: 1.1x)
Volume Ratio Explained
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Sep 28, 2026
Bear Pennant
weak / forming — below our quality gate
quality 44/100
A Bear Pennant is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Historically breaks down 70% of the time (n=1,730). Measured-move targets failed our backtest — none shown.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
About HIND - Vyome Holdings, Inc. Common Stock
Vyome Holdings Inc is a clinical stage specialty pharmaceutical company working to treat immuno-inflammatory diseases including rare indications of unmet need with next-generation therapeutic solutions.
Key Statistics
Market Cap
$14M
More HIND Analysis
This HIND stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track HIND's price movements with trendlines, gamma walls, and key support/resistance levels.